{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T16:25:50Z","timestamp":1789230350611,"version":"build-2803163510"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NO. 82174297"],"award-info":[{"award-number":["NO. 82174297"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s11010-024-05158-y","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:21:03Z","timestamp":1732666863000},"page":"2737-2747","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The role of immunoglobins in atherosclerosis development; friends or foe?"],"prefix":"10.1007","volume":"480","author":[{"given":"Linlin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peize","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wantong","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3821-9388","authenticated-orcid":false,"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,27]]},"reference":[{"issue":"10258","key":"5158_CR1","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"T Vos","year":"2020","unstructured":"Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, Abbasi-Kangevari M, Abbastabar H, Abd-Allah F, Abdelalim A, Abdollahi M (2020) Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396(10258):1204\u20131222","journal-title":"Lancet"},{"issue":"20","key":"5158_CR2","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1016\/j.jacc.2019.10.009","volume":"74","author":"GA Mensah","year":"2019","unstructured":"Mensah GA, Roth GA, Fuster V (2019) The Global burden of cardiovascular diseases and risk factors: 2020 and beyond. J Am Coll Cardiol 74(20):2529\u20132532","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"5158_CR3","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, Bonny A, Brauer M, Brodmann M, Cahill TJ, Carapetis J, Catapano AL, Chugh SS, Cooper LT, Coresh J, Criqui M, DeCleene N, Eagle KA, Emmons-Bell S, Feigin VL, Fern\u00e1ndez-Sol\u00e0 J, Fowkes G, Gakidou E, Grundy SM, He FJ, Howard G, Hu F, Inker L, Karthikeyan G, Kassebaum N, Koroshetz W, Lavie C, Lloyd-Jones D, Lu HS, Mirijello A, Temesgen AM, Mokdad A, Moran AE, Muntner P, Narula J, Neal B, Ntsekhe M, Moraes de Oliveira G, Otto C, Owolabi M, Pratt M, Rajagopalan S, Reitsma M, Ribeiro ALP, Rigotti N, Rodgers A, Sable C, Shakil S, Sliwa-Hahnle K, Stark B, Sundstr\u00f6m J, Timpel P, Tleyjeh IM, Valgimigli M, Vos T, Whelton PK, Yacoub M, Zuhlke L, Murray C, Fuster V (2020) Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study. J Am Coll Cardiol 76(25):2982\u20133021","journal-title":"J Am Coll Cardiol"},{"issue":"9438","key":"5158_CR4","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","volume":"364","author":"S Yusuf","year":"2004","unstructured":"Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364(9438):937\u2013952","journal-title":"Lancet"},{"issue":"10226","key":"5158_CR5","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S0140-6736(19)32008-2","volume":"395","author":"S Yusuf","year":"2020","unstructured":"Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, Brauer M, Kutty VR, Gupta R, Wielgosz A, AlHabib KF, Dans A, Lopez-Jaramillo P, Avezum A, Lanas F, Oguz A, Kruger IM, Diaz R, Yusoff K, Mony P, Chifamba J, Yeates K, Kelishadi R, Yusufali A, Khatib R, Rahman O, Zatonska K, Iqbal R, Wei L, Bo H, Rosengren A, Kaur M, Mohan V, Lear SA, Teo KK, Leong D, O\u2019Donnell M, McKee M, Dagenais G (2020) Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet 395(10226):795\u2013808","journal-title":"Lancet"},{"issue":"10053","key":"5158_CR6","first-page":"1459","volume":"388","author":"OAJL Uthman","year":"2015","unstructured":"Uthman OAJL (2015) (2016) Global, regional, and national life expectancy, all-cause and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the Global Burden of Disease Study. Lancet 388(10053):1459\u20131544","journal-title":"Lancet"},{"issue":"6","key":"5158_CR7","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nrneph.2017.51","volume":"13","author":"A Gister\u00e5","year":"2017","unstructured":"Gister\u00e5 A, Hansson GKJNRN (2017) The immunology of atherosclerosis. Nature Rev Nephrol 13(6):368\u2013380","journal-title":"Nature Rev Nephrol"},{"key":"5158_CR8","doi-asserted-by":"crossref","unstructured":"Tsiantoulas D, Sage AP, Mallat Z, Binder CJ (2015) Targeting B cells in atherosclerosis: closing the gap from bench to bedside. Arterioscl Thromb Vasc Biol 35(2):296\u2013302.","DOI":"10.1161\/ATVBAHA.114.303569"},{"key":"5158_CR9","doi-asserted-by":"crossref","unstructured":"Srikakulapu P, McNamara CAJAJoP-H, Physiology C (2017) B cells and atherosclerosis. Am J Physiol Heart Circul Physiol 312(5):H1060\u2013H1067.","DOI":"10.1152\/ajpheart.00859.2016"},{"issue":"11","key":"5158_CR10","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.3390\/ijms21114082","volume":"21","author":"H Mangge","year":"2020","unstructured":"Mangge H, Pr\u00fcller F, Schnedl W, Renner W, Almer G (2020) Beyond Macrophages and T Cells: B Cells and Immunoglobulins Determine the Fate of the Atherosclerotic Plaque. Int J Mol Sci 21(11):4082","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5158_CR11","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41569-018-0106-9","volume":"16","author":"AP Sage","year":"2019","unstructured":"Sage AP, Tsiantoulas D, Binder CJ, Mallat Z (2019) The role of B cells in atherosclerosis. Nat Rev Cardiol 16(3):180\u2013196","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"5158_CR12","doi-asserted-by":"publisher","first-page":"380","DOI":"10.5114\/ceji.2015.54603","volume":"40","author":"P Conti","year":"2015","unstructured":"Conti P, Shaik-Dasthagirisaeb Y (2015) Atherosclerosis: a chronic inflammatory disease mediated by mast cells. Cent Eur J Immunol 40(3):380\u2013386","journal-title":"Cent Eur J Immunol"},{"issue":"24","key":"5158_CR13","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","volume":"41","author":"J Bor\u00e9n","year":"2020","unstructured":"Bor\u00e9n J, Chapman MJ, Krauss RM, Packard CJ, Bentzon JF, Binder CJ, Daemen MJ, Demer LL, Hegele RA, Nicholls SJ, Nordestgaard BG, Watts GF, Bruckert E, Fazio S, Ference BA, Graham I, Horton JD, Landmesser U, Laufs U, Masana L, Pasterkamp G, Raal FJ, Ray KK, Schunkert H, Taskinen MR, van de Sluis B, Wiklund O, Tokgozoglu L, Catapano AL, Ginsberg HN (2020) Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J 41(24):2313\u20132330","journal-title":"Eur Heart J"},{"key":"5158_CR14","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3389\/fimmu.2020.00284","volume":"11","author":"C Zhong","year":"2020","unstructured":"Zhong C, Yang X, Feng Y, Yu J (2020) Trained immunity: an underlying driver of inflammatory atherosclerosis. Front Immunol 11:284","journal-title":"Front Immunol"},{"issue":"5","key":"5158_CR15","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1056\/NEJM200108023450506","volume":"345","author":"A Davidson","year":"2001","unstructured":"Davidson A, Diamond B (2001) Autoimmune diseases. N Engl J Med 345(5):340\u2013350","journal-title":"N Engl J Med"},{"key":"5158_CR16","doi-asserted-by":"publisher","first-page":"108247","DOI":"10.1016\/j.clim.2019.108247","volume":"212","author":"E Sereti","year":"2020","unstructured":"Sereti E, Stamatelopoulos KS, Zakopoulos NA, Evangelopoulou A, Mavragani CP, Evangelopoulos ME (2020) Hypertension: An immune related disorder? Clin Immunol 212:108247","journal-title":"Clin Immunol"},{"issue":"2","key":"5158_CR17","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"R Ross","year":"1999","unstructured":"Ross R (1999) Atherosclerosis\u2013an inflammatory disease. N Engl J Med 340(2):115\u2013126","journal-title":"N Engl J Med"},{"key":"5158_CR18","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1196\/annals.1361.074","volume":"1051","author":"M Knoflach","year":"2005","unstructured":"Knoflach M, Bernhard D, Wick G (2005) Anti-HSP60 immunity is already associated with atherosclerosis early in life. Ann N Y Acad Sci 1051:323\u2013331","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"5158_CR19","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.atherosclerosis.2015.06.044","volume":"242","author":"C Grundtman","year":"2015","unstructured":"Grundtman C, Jakic B, Buszko M, Onestingel E, Almanzar G, Demetz E, Dietrich H, Cappellano G, Wick G (2015) Mycobacterial heat shock protein 65 (mbHSP65)-induced atherosclerosis: Preventive oral tolerization and definition of atheroprotective and atherogenic mbHSP65 peptides. Atherosclerosis 242(1):303\u2013310","journal-title":"Atherosclerosis"},{"issue":"8","key":"5158_CR20","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1084\/jem.20031557","volume":"199","author":"T Aprahamian","year":"2004","unstructured":"Aprahamian T, Rifkin I, Bonegio R, Hugel B, Freyssinet JM, Sato K, Castellot JJ Jr, Walsh K (2004) Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease. J Exp Med 199(8):1121\u20131131","journal-title":"J Exp Med"},{"issue":"4","key":"5158_CR21","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1194\/jlr.M600512-JLR200","volume":"48","author":"X Feng","year":"2007","unstructured":"Feng X, Li H, Rumbin AA, Wang X, La Cava A, Brechtelsbauer K, Castellani LW, Witztum JL, Lusis AJ, Tsao BP (2007) ApoE-\/-Fas-\/- C57BL\/6 mice: a novel murine model simultaneously exhibits lupus nephritis, atherosclerosis, and osteopenia. J Lipid Res 48(4):794\u2013805","journal-title":"J Lipid Res"},{"issue":"7","key":"5158_CR22","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1161\/ATVBAHA.107.142430","volume":"27","author":"EL Gautier","year":"2007","unstructured":"Gautier EL, Huby T, Ouzilleau B, Doucet C, Saint-Charles F, Gremy G, Chapman MJ, Lesnik P (2007) Enhanced immune system activation and arterial inflammation accelerates atherosclerosis in lupus-prone mice. Arterioscler Thromb Vasc Biol 27(7):1625\u20131631","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"18","key":"5158_CR23","doi-asserted-by":"publisher","first-page":"7018","DOI":"10.1073\/pnas.0602311103","volume":"103","author":"AK Stanic","year":"2006","unstructured":"Stanic AK, Stein CM, Morgan AC, Fazio S, Linton MF, Wakeland EK, Olsen NJ, Major AS (2006) Immune dysregulation accelerates atherosclerosis and modulates plaque composition in systemic lupus erythematosus. Proc Natl Acad Sci U S A 103(18):7018\u20137023","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"5158_CR24","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1002\/art.34451","volume":"64","author":"MJ Lewis","year":"2012","unstructured":"Lewis MJ, Malik TH, Fossati-Jimack L, Carassiti D, Cook HT, Haskard DO, Botto M (2012) Distinct roles for complement in glomerulonephritis and atherosclerosis revealed in mice with a combination of lupus and hyperlipidemia. Arthritis Rheum 64(8):2707\u20132718","journal-title":"Arthritis Rheum"},{"issue":"1","key":"5158_CR25","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.1038\/s41598-017-02771-4","volume":"7","author":"L Temmerman","year":"2017","unstructured":"Temmerman L, Westra MM, Bot I, van Vlijmen BJM, van Bree N, Bot M, Habets KLL, Keulers TGH, van der Vlag J, Cotter TG, van Berkel TJC, Biessen EAL (2017) Leukocyte Bim deficiency does not impact atherogenesis in ldlr (-\/-) mice, despite a pronounced induction of autoimmune inflammation. Sci Rep 7(1):3086","journal-title":"Sci Rep"},{"issue":"9","key":"5158_CR26","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1161\/ATVBAHA.108.179705","volume":"32","author":"P Libby","year":"2012","unstructured":"Libby P (2012) Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol 32(9):2045\u20132051","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"5158_CR27","first-page":"417","volume":"33","author":"IE Konstantinov","year":"2006","unstructured":"Konstantinov IE, Mejevoi N, Anichkov NM, Nikolai N (2006) Anichkov and his theory of atherosclerosis. Tex Heart Inst J 33(4):417\u2013423","journal-title":"Tex Heart Inst J"},{"issue":"4","key":"5158_CR28","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/0021-9150(79)90064-9","volume":"34","author":"W Hollander","year":"1979","unstructured":"Hollander W, Colombo MA, Kirkpatrick B, Paddock J (1979) Soluble proteins in the human atherosclerotic plaque. With spectral reference to immunoglobulins, C3-complement component, alpha 1-antitrypsin and alpha 2-macroglobulin. Atherosclerosis 34(4):391\u2013405","journal-title":"Atherosclerosis"},{"issue":"3","key":"5158_CR29","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/0014-4800(80)90028-3","volume":"33","author":"GK Hansson","year":"1980","unstructured":"Hansson GK, Bondjers G, Bylock A, Hjalmarsson L (1980) Ultrastructural studies on the localization of IgG in the aortic endothelium and subendothelial intima of atherosclerotic and nonatherosclerotic rabbits. Exp Mol Pathol 33(3):302\u2013315","journal-title":"Exp Mol Pathol"},{"issue":"1\u20132","key":"5158_CR30","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0021-9150(81)90118-0","volume":"38","author":"D Parums","year":"1981","unstructured":"Parums D, Mitchinson MJ (1981) Demonstration of immunoglobulin in the neighbourhood of advanced atherosclerotic plaques. Atherosclerosis 38(1\u20132):211\u2013216","journal-title":"Atherosclerosis"},{"issue":"1","key":"5158_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0021-9150(85)90164-9","volume":"55","author":"R Vlaicu","year":"1985","unstructured":"Vlaicu R, Rus HG, Niculescu F, Cristea A (1985) Immunoglobulins and complement components in human aortic atherosclerotic intima. Atherosclerosis 55(1):35\u201350","journal-title":"Atherosclerosis"},{"issue":"2","key":"5158_CR32","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1194\/jlr.P054569","volume":"56","author":"D Tsiantoulas","year":"2015","unstructured":"Tsiantoulas D, Perkmann T, Afonyushkin T, Mangold A, Prohaska TA, Papac-Milicevic N, Millischer V, Bartel C, H\u00f6rkk\u00f6 S, Boulanger CM, Tsimikas S, Fischer MB, Witztum JL, Lang IM, Binder CJ (2015) Circulating microparticles carry oxidation-specific epitopes and are recognized by natural IgM antibodies. J Lipid Res 56(2):440\u2013448","journal-title":"J Lipid Res"},{"issue":"8","key":"5158_CR33","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/nri.2016.63","volume":"16","author":"CJ Binder","year":"2016","unstructured":"Binder CJ, Papac-Milicevic N, Witztum JL (2016) Innate sensing of oxidation-specific epitopes in health and disease. Nat Rev Immunol 16(8):485\u2013497","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"5158_CR34","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1172\/JCI118853","volume":"98","author":"W Palinski","year":"1996","unstructured":"Palinski W, H\u00f6rkk\u00f6 S, Miller E, Steinbrecher UP, Powell HC, Curtiss LK, Witztum JL (1996) Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J Clin Invest 98(3):800\u2013814","journal-title":"J Clin Invest"},{"issue":"13","key":"5158_CR35","doi-asserted-by":"publisher","first-page":"9163","DOI":"10.1074\/jbc.275.13.9163","volume":"275","author":"A Boullier","year":"2000","unstructured":"Boullier A, Gillotte KL, H\u00f6rkk\u00f6 S, Green SR, Friedman P, Dennis EA, Witztum JL, Steinberg D, Quehenberger O (2000) The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein. J Biol Chem 275(13):9163\u20139169","journal-title":"J Biol Chem"},{"issue":"9","key":"5158_CR36","doi-asserted-by":"publisher","first-page":"7010","DOI":"10.1074\/jbc.M108860200","volume":"277","author":"P Friedman","year":"2002","unstructured":"Friedman P, Horkko S, Steinberg D, Witztum JL, Dennis EA (2002) Correlation of antiphospholipid antibody recognition with the structure of synthetic oxidized phospholipids. Importance of Schiff base formation and aldol condensation. J Biol Chem 277(9):7010\u20137020","journal-title":"J Biol Chem"},{"issue":"6","key":"5158_CR37","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.4049\/jimmunol.1202870","volume":"191","author":"M Hamze","year":"2013","unstructured":"Hamze M, Desmetz C, Berthe ML, Roger P, Boulle N, Brancherau P, Picard E, Guzman C, Tolza C, Guglielmi P (2013) Characterization of resident B cells of vascular walls in human atherosclerotic patients. J Immunol 191(6):3006\u20133016","journal-title":"J Immunol"},{"issue":"12","key":"5158_CR38","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1161\/CIRCRESAHA.117.312513","volume":"122","author":"H Winkels","year":"2018","unstructured":"Winkels H, Ehinger E, Vassallo M, Buscher K, Dinh HQ, Kobiyama K, Hamers AAJ, Cochain C, Vafadarnejad E, Saliba AE, Zernecke A, Pramod AB, Ghosh AK, Anto Michel N, Hoppe N, Hilgendorf I, Zirlik A, Hedrick CC, Ley K, Wolf D (2018) Atlas of the immune cell repertoire in mouse atherosclerosis defined by single-cell RNA-sequencing and mass cytometry. Circ Res 122(12):1675\u20131688","journal-title":"Circ Res"},{"issue":"6","key":"5158_CR39","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1161\/ATVBAHA.112.300112","volume":"33","author":"T Huan","year":"2013","unstructured":"Huan T, Zhang B, Wang Z, Joehanes R, Zhu J, Johnson AD, Ying S, Munson PJ, Raghavachari N, Wang R, Liu P, Courchesne P, Hwang SJ, Assimes TL, McPherson R, Samani NJ, Schunkert H, Meng Q, Suver C, O\u2019Donnell CJ, Derry J, Yang X, Levy D (2013) A systems biology framework identifies molecular underpinnings of coronary heart disease. Arterioscler Thromb Vasc Biol 33(6):1427\u20131434","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"5158_CR40","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1161\/ATVBAHA.113.302667","volume":"34","author":"PT Mantani","year":"2014","unstructured":"Mantani PT, Ljungcrantz I, Andersson L, Alm R, Hedblad B, Bj\u00f6rkbacka H, Nilsson J, Fredrikson GN (2014) Circulating CD40+ and CD86+ B cell subsets demonstrate opposing associations with risk of stroke. Arterioscler Thromb Vasc Biol 34(1):211\u2013218","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"5158_CR41","doi-asserted-by":"publisher","first-page":"e005747","DOI":"10.1161\/JAHA.117.005747","volume":"6","author":"JAL Meeuwsen","year":"2017","unstructured":"Meeuwsen JAL, van Duijvenvoorde A, Gohar A, Kozma MO, van de Weg SM, Gijsberts CM, Haitjema S, Bj\u00f6rkbacka H, Fredrikson GN, de Borst GJ, den Ruijter HM, Pasterkamp G, Binder CJ, Hoefer IE, de Jager SCA (2017) High Levels of (Un)Switched Memory B Cells Are Associated With Better Outcome in Patients With Advanced Atherosclerotic Disease. J Am Heart Assoc 6(9):e005747","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"5158_CR42","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1172\/JCI7272","volume":"109","author":"G Caligiuri","year":"2002","unstructured":"Caligiuri G, Nicoletti A, Poirier B, Hansson GK (2002) Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J Clin Invest 109(6):745\u2013753","journal-title":"J Clin Invest"},{"issue":"11","key":"5158_CR43","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1161\/01.ATV.0000039169.47943.EE","volume":"22","author":"AS Major","year":"2002","unstructured":"Major AS, Fazio S, Linton MF (2002) B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice. Arterioscler Thromb Vasc Biol 22(11):1892\u20131898","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1\u20132","key":"5158_CR44","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0021-9150(88)90204-3","volume":"74","author":"A Muscari","year":"1988","unstructured":"Muscari A, Bozzoli C, Gerratana C, Zaca F, Rovinetti C, Zauli D, La Placa M, Puddu P (1988) Association of serum IgA and C4 with severe atherosclerosis. Atherosclerosis 74(1\u20132):179\u2013186","journal-title":"Atherosclerosis"},{"issue":"6","key":"5158_CR45","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.immuni.2015.05.015","volume":"42","author":"D Hu","year":"2015","unstructured":"Hu D, Mohanta SK, Yin C, Peng L, Ma Z, Srikakulapu P, Grassia G, MacRitchie N, Dever G, Gordon P, Burton FL, Ialenti A, Sabir SR, McInnes IB, Brewer JM, Garside P, Weber C, Lehmann T, Teupser D, Habenicht L, Beer M, Grabner R, Maffia P, Weih F, Habenicht AJ (2015) Artery tertiary lymphoid organs control aorta immunity and protect against atherosclerosis via vascular smooth muscle cell lymphotoxin \u03b2 receptors. Immunity 42(6):1100\u20131115","journal-title":"Immunity"},{"issue":"6","key":"5158_CR46","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1161\/ATVBAHA.115.306983","volume":"36","author":"P Srikakulapu","year":"2016","unstructured":"Srikakulapu P, Hu D, Yin C, Mohanta SK, Bontha SV, Peng L, Beer M, Weber C, McNamara CA, Grassia G, Maffia P, Manz RA, Habenicht AJ (2016) Artery tertiary lymphoid organs control multilayered territorialized atherosclerosis b-cell responses in aged ApoE-\/- Mice. Arterioscler Thromb Vasc Biol 36(6):1174\u20131185","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"5158_CR47","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/j.1365-2559.1990.tb00794.x","volume":"17","author":"AL Ramshaw","year":"1990","unstructured":"Ramshaw AL, Parums DV (1990) Immunohistochemical characterization of inflammatory cells associated with advanced atherosclerosis. Histopathology 17(6):543\u2013552","journal-title":"Histopathology"},{"issue":"12","key":"5158_CR48","first-page":"965","volume":"6","author":"DD Miller","year":"1995","unstructured":"Miller DD, Craig FE, Dressler FA, Aguirre FV, Farrar MA, Breland CM, Donohue TJ, Kern MJ, Bach RG (1995) Immunohistochemical characterization of immune cell composition and cytokine receptor expression in human coronary atherectomy tissue. Coron Artery Dis 6(12):965\u2013972","journal-title":"Coron Artery Dis"},{"issue":"2","key":"5158_CR49","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH774>3.0.CO;2-N","volume":"193","author":"MA Houtkamp","year":"2001","unstructured":"Houtkamp MA, de Boer OJ, van der Loos CM, van der Wal AC, Becker AE (2001) Adventitial infiltrates associated with advanced atherosclerotic plaques: structural organization suggests generation of local humoral immune responses. J Pathol 193(2):263\u2013269","journal-title":"J Pathol"},{"issue":"24","key":"5158_CR50","doi-asserted-by":"publisher","first-page":"e013793","DOI":"10.1161\/JAHA.119.013793","volume":"8","author":"DS Farias-Itao","year":"2019","unstructured":"Farias-Itao DS, Pasqualucci CA, Nishizawa A, da Silva LFF, Campos FM, Bittencourt MS, da Silva KCS, Leite REP, Grinberg LT, Ferretti-Rebustini REL, Jacob-Filho W, Suemoto CK (2019) B lymphocytes and macrophages in the perivascular adipose tissue are associated with coronary atherosclerosis: an autopsy study. J Am Heart Assoc 8(24):e013793","journal-title":"J Am Heart Assoc"},{"key":"5158_CR51","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3389\/fphys.2017.00719","volume":"8","author":"P Srikakulapu","year":"2017","unstructured":"Srikakulapu P, Upadhye A, Rosenfeld SM, Marshall MA, McSkimming C, Hickman AW, Mauldin IS, Ailawadi G, Lopes MBS, Taylor AM, McNamara CA (2017) Perivascular Adipose Tissue Harbors Atheroprotective IgM-Producing B Cells. Front Physiol 8:719","journal-title":"Front Physiol"},{"issue":"13","key":"5158_CR52","first-page":"2544","volume":"117","author":"F Porsch","year":"2021","unstructured":"Porsch F, Mallat Z, Binder CJ (2021) Humoral immunity in atherosclerosis and myocardial infarction: from B cells to antibodies. Cardiovasc Res 117(13):2544\u20132562","journal-title":"Cardiovasc Res"},{"issue":"10","key":"5158_CR53","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1161\/CIRCRESAHA.119.315786","volume":"125","author":"A Upadhye","year":"2019","unstructured":"Upadhye A, Srikakulapu P, Gonen A, Hendrikx S, Perry HM, Nguyen A, McSkimming C, Marshall MA, Garmey JC, Taylor AM, Bender TP, Tsimikas S, Holodick NE, Rothstein TL, Witztum JL, McNamara CA (2019) Diversification and CXCR4-dependent establishment of the bone marrow B-1a cell pool governs atheroprotective IgM production linked to human coronary atherosclerosis. Circ Res 125(10):e55\u2013e70","journal-title":"Circ Res"},{"key":"5158_CR54","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev-immunol-042617-053104","volume":"38","author":"L Adamo","year":"2020","unstructured":"Adamo L, Rocha-Resende C, Mann DL (2020) The emerging role of B lymphocytes in cardiovascular disease. Annu Rev Immunol 38:99\u2013121","journal-title":"Annu Rev Immunol"},{"issue":"6","key":"5158_CR55","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.jacbts.2021.01.006","volume":"6","author":"T Pattarabanjird","year":"2021","unstructured":"Pattarabanjird T, Li C, McNamara C (2021) B cells in atherosclerosis: mechanisms and potential clinical applications. JACC Basic Transl Sci 6(6):546\u2013563","journal-title":"JACC Basic Transl Sci"},{"issue":"7","key":"5158_CR56","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.4049\/jimmunol.1000033","volume":"185","author":"T Kyaw","year":"2010","unstructured":"Kyaw T, Tay C, Khan A, Dumouchel V, Cao A, To K, Kehry M, Dunn R, Agrotis A, Tipping P, Bobik A, Toh BH (2010) Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis. J Immunol 185(7):4410\u20134419","journal-title":"J Immunol"},{"issue":"8","key":"5158_CR57","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1084\/jem.20100155","volume":"207","author":"H Ait-Oufella","year":"2010","unstructured":"Ait-Oufella H, Herbin O, Bouaziz JD, Binder CJ, Uyttenhove C, Laurans L, Taleb S, Van Vr\u00e9 E, Esposito B, Vilar J, Sirvent J, Van Snick J, Tedgui A, Tedder TF, Mallat Z (2010) B cell depletion reduces the development of atherosclerosis in mice. J Exp Med 207(8):1579\u20131587","journal-title":"J Exp Med"},{"issue":"1","key":"5158_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029371","volume":"7","author":"T Kyaw","year":"2012","unstructured":"Kyaw T, Tay C, Hosseini H, Kanellakis P, Gadowski T, MacKay F, Tipping P, Bobik A, Toh BH (2012) Depletion of B2 but not B1a B cells in BAFF receptor-deficient ApoE mice attenuates atherosclerosis by potently ameliorating arterial inflammation. PLoS ONE 7(1):e29371","journal-title":"PLoS ONE"},{"issue":"7","key":"5158_CR59","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1161\/ATVBAHA.111.244731","volume":"32","author":"AP Sage","year":"2012","unstructured":"Sage AP, Tsiantoulas D, Baker L, Harrison J, Masters L, Murphy D, Loinard C, Binder CJ, Mallat Z (2012) BAFF receptor deficiency reduces the development of atherosclerosis in mice\u2013brief report. Arterioscler Thromb Vasc Biol 32(7):1573\u20131576","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"5158_CR60","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/nm.4315","volume":"23","author":"M Nus","year":"2017","unstructured":"Nus M, Sage AP, Lu Y, Masters L, Lam BYH, Newland S, Weller S, Tsiantoulas D, Raffort J, Marcus D, Finigan A, Kitt L, Figg N, Schirmbeck R, Kneilling M, Yeo GSH, Binder CJ, de la Pompa JL, Mallat Z (2017) Marginal zone B cells control the response of follicular helper T cells to a high-cholesterol diet. Nat Med 23(5):601\u2013610","journal-title":"Nat Med"},{"issue":"16","key":"5158_CR61","doi-asserted-by":"publisher","first-page":"E2030","DOI":"10.1073\/pnas.1421227112","volume":"112","author":"EK Grasset","year":"2015","unstructured":"Grasset EK, Duhlin A, Agardh HE, Ovchinnikova O, H\u00e4ggl\u00f6f T, Forsell MN, Paulsson-Berne G, Hansson GK, Ketelhuth DF, Karlsson MC (2015) Sterile inflammation in the spleen during atherosclerosis provides oxidation-specific epitopes that induce a protective B-cell response. Proc Natl Acad Sci U S A 112(16):E2030-2038","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"21","key":"5158_CR62","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1161\/CIRCULATIONAHA.118.038534","volume":"139","author":"M Centa","year":"2019","unstructured":"Centa M, Jin H, Hofste L, Hellberg S, Busch A, Baumgartner R, Verzaal NJ, Lind Enoksson S, Perisic Matic L, Boddul SV, Atzler D, Li DY, Sun C, Hansson GK, Ketelhuth DFJ, Hedin U, Wermeling F, Lutgens E, Binder CJ, Maegdesfessel L, Malin SG (2019) Germinal center-derived antibodies promote atherosclerosis plaque size and stability. Circulation 139(21):2466\u20132482","journal-title":"Circulation"},{"issue":"5","key":"5158_CR63","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1161\/ATVBAHA.117.310678","volume":"38","author":"C Tay","year":"2018","unstructured":"Tay C, Liu YH, Kanellakis P, Kallies A, Li Y, Cao A, Hosseini H, Tipping P, Toh BH, Bobik A, Kyaw T (2018) Follicular B cells promote atherosclerosis via T cell-mediated differentiation into plasma cells and secreting pathogenic immunoglobulin G. Arterioscler Thromb Vasc Biol 38(5):e71\u2013e84","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"5158_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/jci.insight.120137","volume":"3","author":"L Adamo","year":"2018","unstructured":"Adamo L, Staloch LJ, Rocha-Resende C, Matkovich SJ, Jiang W, Bajpai G, Weinheimer CJ, Kovacs A, Schilling JD, Barger PM, Bhattacharya D, Mann DL (2018) Modulation of subsets of cardiac B lymphocytes improves cardiac function after acute injury. JCI Insight 3(11):1","journal-title":"JCI Insight"},{"issue":"3","key":"5158_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/jci.insight.134700","volume":"5","author":"L Adamo","year":"2020","unstructured":"Adamo L, Rocha-Resende C, Lin CY, Evans S, Williams J, Dun H, Li W, Mpoy C, Andhey PS, Rogers BE, Lavine K, Kreisel D, Artyomov M, Randolph GJ, Mann DL (2020) Myocardial B cells are a subset of circulating lymphocytes with delayed transit through the heart. JCI Insight 5(3):1","journal-title":"JCI Insight"},{"issue":"9","key":"5158_CR66","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1161\/CIRCULATIONAHA.117.028833","volume":"137","author":"M Horckmans","year":"2018","unstructured":"Horckmans M, Bianchini M, Santovito D, Megens RTA, Springael JY, Negri I, Vacca M, Di Eusanio M, Moschetta A, Weber C, Duchene J, Steffens S (2018) Pericardial adipose tissue regulates granulopoiesis, fibrosis, and cardiac function after myocardial infarction. Circulation 137(9):948\u2013960","journal-title":"Circulation"},{"key":"5158_CR67","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.yjmcc.2013.04.023","volume":"62","author":"X Yan","year":"2013","unstructured":"Yan X, Anzai A, Katsumata Y, Matsuhashi T, Ito K, Endo J, Yamamoto T, Takeshima A, Shinmura K, Shen W, Fukuda K, Sano M (2013) Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction. J Mol Cell Cardiol 62:24\u201335","journal-title":"J Mol Cell Cardiol"},{"issue":"10","key":"5158_CR68","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/nm.3284","volume":"19","author":"Y Zouggari","year":"2013","unstructured":"Zouggari Y, Ait-Oufella H, Bonnin P, Simon T, Sage AP, Gu\u00e9rin C, Vilar J, Caligiuri G, Tsiantoulas D, Laurans L, Dumeau E, Kotti S, Bruneval P, Charo IF, Binder CJ, Danchin N, Tedgui A, Tedder TF, Silvestre JS, Mallat Z (2013) B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction. Nat Med 19(10):1273\u20131280","journal-title":"Nat Med"},{"issue":"10","key":"5158_CR69","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.jcin.2009.08.010","volume":"2","author":"TT Goodchild","year":"2009","unstructured":"Goodchild TT, Robinson KA, Pang W, Tondato F, Cui J, Arrington J, Godwin L, Ungs M, Carlesso N, Weich N, Poznansky MC, Chronos NA (2009) Bone marrow-derived B cells preserve ventricular function after acute myocardial infarction. JACC Cardiovasc Interv 2(10):1005\u20131016","journal-title":"JACC Cardiovasc Interv"},{"issue":"13","key":"5158_CR70","first-page":"2664","volume":"117","author":"M Heinrichs","year":"2021","unstructured":"Heinrichs M, Ashour D, Siegel J, B\u00fcchner L, Wedekind G, Heinze KG, Arampatzi P, Saliba AE, Cochain C, Hofmann U, Frantz S, Campos Ramos G (2021) The healing myocardium mobilizes a distinct B-cell subset through a CXCL13-CXCR5-dependent mechanism. Cardiovasc Res 117(13):2664\u20132676","journal-title":"Cardiovasc Res"},{"key":"5158_CR71","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3389\/fcell.2020.00695","volume":"8","author":"A Sintou","year":"2020","unstructured":"Sintou A, Mansfield C, Iacob A, Chowdhury RA, Narodden S, Rothery SM, Podovei R, Sanchez-Alonso JL, Ferraro E, Swiatlowska P, Harding SE, Prasad S, Rosenthal N, Gorelik J, Sattler S (2020) Mediastinal lymphadenopathy, class-switched auto-antibodies and myocardial immune-complexes during heart failure in rodents and humans. Front Cell Dev Biol 8:695","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"5158_CR72","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1161\/CIRCRESAHA.111.243360","volume":"110","author":"Z Kaya","year":"2012","unstructured":"Kaya Z, Leib C, Katus HA (2012) Autoantibodies in heart failure and cardiac dysfunction. Circ Res 110(1):145\u2013158","journal-title":"Circ Res"},{"key":"5158_CR73","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ijcard.2016.02.035","volume":"209","author":"TJ O'Donohoe","year":"2016","unstructured":"O\u2019Donohoe TJ, Schrale RG, Ketheesan N (2016) The role of anti-myosin antibodies in perpetuating cardiac damage following myocardial infarction. Int J Cardiol 209:226\u2013233","journal-title":"Int J Cardiol"},{"issue":"5","key":"5158_CR74","doi-asserted-by":"publisher","first-page":"H1358","DOI":"10.1152\/ajpheart.00144.2018","volume":"315","author":"L Keppner","year":"2018","unstructured":"Keppner L, Heinrichs M, Rieckmann M, Demengeot J, Frantz S, Hofmann U, Ramos G (2018) Antibodies aggravate the development of ischemic heart failure. Am J Physiol Heart Circ Physiol 315(5):H1358-h1367","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"5158_CR75","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.yjmcc.2006.02.006","volume":"41","author":"M Zhang","year":"2006","unstructured":"Zhang M, Michael LH, Grosjean SA, Kelly RA, Carroll MC, Entman ML (2006) The role of natural IgM in myocardial ischemia-reperfusion injury. J Mol Cell Cardiol 41(1):62\u201367","journal-title":"J Mol Cell Cardiol"},{"issue":"43","key":"5158_CR76","doi-asserted-by":"publisher","first-page":"21673","DOI":"10.1073\/pnas.1911464116","volume":"116","author":"L Wu","year":"2019","unstructured":"Wu L, Dalal R, Cao CD, Postoak JL, Yang G, Zhang Q, Wang Z, Lal H, Van Kaer L (2019) IL-10-producing B cells are enriched in murine pericardial adipose tissues and ameliorate the outcome of acute myocardial infarction. Proc Natl Acad Sci U S A 116(43):21673\u201321684","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"5158_CR77","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/nrcardio.2011.62","volume":"8","author":"C Lahoute","year":"2011","unstructured":"Lahoute C, Herbin O, Mallat Z, Tedgui A (2011) Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets. Nat Rev Cardiol 8(6):348\u2013358","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"5158_CR78","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1172\/JCI63108","volume":"123","author":"AH Lichtman","year":"2013","unstructured":"Lichtman AH, Binder CJ, Tsimikas S, Witztum JL (2013) Adaptive immunity in atherogenesis: new insights and therapeutic approaches. J Clin Invest 123(1):27\u201336","journal-title":"J Clin Invest"},{"issue":"1","key":"5158_CR79","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.clim.2009.07.009","volume":"134","author":"S Amir","year":"2010","unstructured":"Amir S, Binder CJ (2010) Experimental immunotherapeutic approaches for atherosclerosis. Clin Immunol 134(1):66\u201379","journal-title":"Clin Immunol"},{"issue":"12","key":"5158_CR80","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1084\/jem.20040119","volume":"199","author":"J Uchida","year":"2004","unstructured":"Uchida J, Hamaguchi Y, Oliver JA, Ravetch JV, Poe JC, Haas KM, Tedder TF (2004) The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy. J Exp Med 199(12):1659\u20131669","journal-title":"J Exp Med"},{"issue":"4","key":"5158_CR81","doi-asserted-by":"publisher","first-page":"e60430","DOI":"10.1371\/journal.pone.0060430","volume":"8","author":"T Kyaw","year":"2013","unstructured":"Kyaw T, Cui P, Tay C, Kanellakis P, Hosseini H, Liu E, Rolink AG, Tipping P, Bobik A, Toh BH (2013) BAFF receptor mAb treatment ameliorates development and progression of atherosclerosis in hyperlipidemic ApoE(-\/-) mice. PLoS ONE 8(4):e60430","journal-title":"PLoS ONE"},{"issue":"12","key":"5158_CR82","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1038\/sj.jid.5700919","volume":"127","author":"T Matsushita","year":"2007","unstructured":"Matsushita T, Fujimoto M, Hasegawa M, Matsushita Y, Komura K, Ogawa F, Watanabe R, Takehara K, Sato S (2007) BAFF antagonist attenuates the development of skin fibrosis in tight-skin mice. J Invest Dermatol 127(12):2772\u20132780","journal-title":"J Invest Dermatol"},{"issue":"7","key":"5158_CR83","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nri2572","volume":"9","author":"F Mackay","year":"2009","unstructured":"Mackay F, Schneider P (2009) Cracking the BAFF code. Nat Rev Immunol 9(7):491\u2013502","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"5158_CR84","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S1074-7613(01)00183-2","volume":"15","author":"JA Gross","year":"2001","unstructured":"Gross JA, Dillon SR, Mudri S, Johnston J, Littau A, Roque R, Rixon M, Schou O, Foley KP, Haugen H, McMillen S, Waggie K, Schreckhise RW, Shoemaker K, Vu T, Moore M, Grossman A, Clegg CH (2001) TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. Impaired B cell maturation in mice lacking BLyS. Immunity 15(2):289\u2013302","journal-title":"Immunity"},{"issue":"1","key":"5158_CR85","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1084\/jem.20031330","volume":"199","author":"BP O'Connor","year":"2004","unstructured":"O\u2019Connor BP, Raman VS, Erickson LD, Cook WJ, Weaver LK, Ahonen C, Lin LL, Mantchev GT, Bram RJ, Noelle RJ (2004) BCMA is essential for the survival of long-lived bone marrow plasma cells. J Exp Med 199(1):91\u201398","journal-title":"J Exp Med"},{"issue":"11","key":"5158_CR86","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1161\/CIRCRESAHA.113.301145","volume":"114","author":"D Tsiantoulas","year":"2014","unstructured":"Tsiantoulas D, Diehl CJ, Witztum JL, Binder CJ (2014) B cells and humoral immunity in atherosclerosis. Circ Res 114(11):1743\u20131756","journal-title":"Circ Res"},{"issue":"21","key":"5158_CR87","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1182\/blood-2014-02-548610","volume":"123","author":"SE Herman","year":"2014","unstructured":"Herman SE, Mustafa RZ, Gyamfi JA, Pittaluga S, Chang S, Chang B, Farooqui M, Wiestner A (2014) Ibrutinib inhibits BCR and NF-\u03baB signaling and reduces tumor proliferation in tissue-resident cells of patients with CLL. Blood 123(21):3286\u20133295","journal-title":"Blood"},{"issue":"7","key":"5158_CR88","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.4049\/jimmunol.174.7.4389","volume":"174","author":"Y Hamaguchi","year":"2005","unstructured":"Hamaguchi Y, Uchida J, Cain DW, Venturi GM, Poe JC, Haas KM, Tedder TF (2005) The peritoneal cavity provides a protective niche for B1 and conventional B lymphocytes during anti-CD20 immunotherapy in mice. J Immunol 174(7):4389\u20134399","journal-title":"J Immunol"},{"issue":"9","key":"5158_CR89","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1056\/NEJMoa1609783","volume":"376","author":"H Kantarjian","year":"2017","unstructured":"Kantarjian H, Stein A, G\u00f6kbuget N, Fielding AK, Schuh AC, Ribera JM, Wei A, Dombret H, Fo\u00e0 R, Bassan R, Arslan \u00d6, Sanz MA, Bergeron J, Demirkan F, Lech-Maranda E, Rambaldi A, Thomas X, Horst HA, Br\u00fcggemann M, Klapper W, Wood BL, Fleishman A, Nagorsen D, Holland C, Zimmerman Z, Topp MS (2017) Blinatumomab versus chemotherapy for advanced acute lymphoblastic leukemia. N Engl J Med 376(9):836\u2013847","journal-title":"N Engl J Med"},{"issue":"8","key":"5158_CR90","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1056\/NEJMoa1509277","volume":"375","author":"HM Kantarjian","year":"2016","unstructured":"Kantarjian HM, DeAngelo DJ, Stelljes M, Martinelli G, Liedtke M, Stock W, G\u00f6kbuget N, O\u2019Brien S, Wang K, Wang T, Paccagnella ML, Sleight B, Vandendries E, Advani AS (2016) Inotuzumab ozogamicin versus standard therapy for acute lymphoblastic leukemia. N Engl J Med 375(8):740\u2013753","journal-title":"N Engl J Med"},{"issue":"1","key":"5158_CR91","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13045-016-0284-z","volume":"9","author":"Y Wang","year":"2016","unstructured":"Wang Y, Sanchez L, Siegel DS, Wang ML (2016) Elotuzumab for the treatment of multiple myeloma. J Hematol Oncol 9(1):55","journal-title":"J Hematol Oncol"},{"key":"5158_CR92","doi-asserted-by":"publisher","first-page":"204062071989487","DOI":"10.1177\/2040620719894871","volume":"10","author":"N Abdallah","year":"2019","unstructured":"Abdallah N, Kumar SK (2019) Daratumumab in untreated newly diagnosed multiple myeloma. Ther Adv Hematol 10:2040620719894871","journal-title":"Ther Adv Hematol"},{"issue":"12","key":"5158_CR93","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/S1470-2045(18)30576-X","volume":"19","author":"S Trudel","year":"2018","unstructured":"Trudel S, Lendvai N, Popat R, Voorhees PM, Reeves B, Libby EN, Richardson PG, Anderson LD Jr, Sutherland HJ, Yong K, Hoos A, Gorczyca MM, Lahiri S, He Z, Austin DJ, Opalinska JB, Cohen AD (2018) Targeting B-cell maturation antigen with GSK2857916 antibody-drug conjugate in relapsed or refractory multiple myeloma (BMA117159): a dose escalation and expansion phase 1 trial. Lancet Oncol 19(12):1641\u20131653","journal-title":"Lancet Oncol"},{"issue":"3","key":"5158_CR94","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41408-019-0183-y","volume":"9","author":"C Plummer","year":"2019","unstructured":"Plummer C, Driessen C, Szabo Z, Mateos MV (2019) Management of cardiovascular risk in patients with multiple myeloma. Blood Cancer J 9(3):26","journal-title":"Blood Cancer J"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-024-05158-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-024-05158-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-024-05158-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T13:24:29Z","timestamp":1746192269000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-024-05158-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,27]]},"references-count":94,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["5158"],"URL":"https:\/\/doi.org\/10.1007\/s11010-024-05158-y","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,27]]},"assertion":[{"value":"29 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"It is not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"It is not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"It is not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and resource"}}]}}